연구동향 분석

At Least One Cyclic Teriparatide Administration Can Be Helpful to Delay Initial Onset of a New Osteoporotic Vertebral Compression Fracture

석경수 이병호 이환모 문성환 김희준 김학선 박진오 2014년

논문상세정보
인용/피인용
' At Least One Cyclic Teriparatide Administration Can Be Helpful to Delay Initial Onset of a New Osteoporotic Vertebral Compression Fracture' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • duration
  • osteoporosis
  • teriparatide
  • vertebral compression fracture
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,935 0

0.0%

' At Least One Cyclic Teriparatide Administration Can Be Helpful to Delay Initial Onset of a New Osteoporotic Vertebral Compression Fracture' 의 참고문헌

  • Vertebroplasty: when randomized placebo-controlled trial results clash with common belief
    Buchbinder R. Spine J 10 : 241 ~ 243 [2010]
  • Vertebroplasty: when randomized placebo-controlled trial results clash with common belief
    Buchbinder R. Spine J 10 241-243 [2010]
  • Vertebroplasty and kyphoplasty are associated with an increased risk of secondary vertebral compression fractures: a population-based cohort study
    Mudano AS Osteoporos Int 20 : 819 ~ 826 [2009]
  • Vertebroplasty and kyphoplasty are associated with an increased risk of secondary vertebral compression fractures: a population-based cohort study
    Mudano AS Osteoporos Int 20 819-826 [2009]
  • The Incidence of New Vertebral Compression Fractures in Women after Kyphoplasty and Factors Involved
    문은수 Yonsei Medical Journal 48 (4) : 645 ~ 652 [2007]
  • The Incidence of New Vertebral Compression Fractures in Women after Kyphoplasty and Factors Involved
    문은수 Yonsei Medical Journal 48 4 645-652 [2007]
  • Teriparatide: a review of its use in osteoporosis
    Blick SK Drugs 68 : 2709 ~ 2737 [2008]
  • Teriparatide: a review of its use in osteoporosis
    Blick SK Drugs 68 2709-2737 [2008]
  • Risk factors for new osteoporotic vertebral compression fractures after vertebroplasty: a systematic review and meta-analysis
    Zhang Z J Spinal Disord Tech 26 : E150 ~ E157 [2013]
  • Risk factors for new osteoporotic vertebral compression fractures after vertebroplasty: a systematic review and meta-analysis
    Zhang Z J Spinal Disord Tech 26 E150-E157 [2013]
  • Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis
    Martin TJ Osteoporos Int 19 : 1125 ~ 1138 [2008]
  • Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis
    Martin TJ Osteoporos Int 19 1125-1138 [2008]
  • Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
    Ettinger B JAMA 282 : 637 ~ 645 [1999]
  • Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
    Ettinger B JAMA 282 637-645 [1999]
  • Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis
    Nevitt MC Osteoporos Int 17 : 1630 ~ 1637 [2006]
  • Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis
    Nevitt MC Osteoporos Int 17 1630-1637 [2006]
  • Reduced risk of back pain following teriparatide treatment: a meta-analysis
    Nevitt MC Osteoporos Int 17 : 273 ~ 280 [2006]
  • Reduced risk of back pain following teriparatide treatment: a meta-analysis
    Nevitt MC Osteoporos Int 17 273-280 [2006]
  • Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure
    Jiang Y J Bone Miner Res 18 : 1932 ~ 1941 [2003]
  • Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure
    Jiang Y J Bone Miner Res 18 1932-1941 [2003]
  • Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group
    Black DM Lancet 348 : 1535 ~ 1541 [1996]
  • Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group
    Black DM Lancet 348 1535-1541 [1996]
  • Prospective comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture after percutaneous vertebroplasty
    Tseng YY Osteoporos Int 23 : 1613 ~ 1622 [2012]
  • Prospective comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture after percutaneous vertebroplasty
    Tseng YY Osteoporos Int 23 1613-1622 [2012]
  • Prospective clinical follow-up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures
    Voormolen MH J Vasc Interv Radiol 17 : 1313 ~ 1320 [2006]
  • Prospective clinical follow-up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures
    Voormolen MH J Vasc Interv Radiol 17 1313-1320 [2006]
  • Preventive effects of conservative treatment with short-term teriparatide on the progression of vertebral body collapse after osteoporotic vertebral compression fracture
    Park JH OSTEOPOROSIS INTERNATIONAL 25 (2) : 613 ~ 618 [2014]
  • Preventive effects of conservative treatment with short-term teriparatide on the progression of vertebral body collapse after osteoporotic vertebral compression fracture
    Park JH OSTEOPOROSIS INTERNATIONAL 25 2 613-618 [2014]
  • Osteoporosis
    Sambrook P Lancet 367 : 2010 ~ 2018 [2006]
  • Osteoporosis
    Sambrook P Lancet 367 2010-2018 [2006]
  • Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass
    McClung MR Arch Intern Med 165 : 1762 ~ 1768 [2005]
  • Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass
    McClung MR Arch Intern Med 165 1762-1768 [2005]
  • New fractures after vertebroplasty: adjacent fractures occur significantly sooner
    Trout AT AJNR Am J Neuroradiol 27 : 217 ~ 223 [2006]
  • New fractures after vertebroplasty: adjacent fractures occur significantly sooner
    Trout AT AJNR Am J Neuroradiol 27 217-223 [2006]
  • Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group
    Ravn P J Bone Miner Res 14 : 1622 ~ 1627 [1999]
  • Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group
    Ravn P J Bone Miner Res 14 1622-1627 [1999]
  • Lateral vertebral assessment: a valuable technique to detect clinically significant vertebral fractures
    Binkley N Osteoporos Int 16 : 1513 ~ 1518 [2005]
  • Lateral vertebral assessment: a valuable technique to detect clinically significant vertebral fractures
    Binkley N Osteoporos Int 16 1513-1518 [2005]
  • Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis
    Finkelstein JS J Clin Endocrinol Metab 95 : 1838 ~ 1845 [2010]
  • Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis
    Finkelstein JS J Clin Endocrinol Metab 95 1838-1845 [2010]
  • Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study
    Dempster DW J Bone Miner Res 16 : 1846 ~ 1853 [2001]
  • Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study
    Dempster DW J Bone Miner Res 16 1846-1853 [2001]
  • Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium
    Lindsay R J Bone Miner Res 22 : 495 ~ 502 [2007]
  • Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium
    Lindsay R J Bone Miner Res 22 495-502 [2007]
  • Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
    Neer RM N Engl J Med 344 : 1434 ~ 1441 [2001]
  • Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
    Neer RM N Engl J Med 344 1434-1441 [2001]
  • Development and use of FRAX® in osteoporosis
    Kanis JA Osteoporos Int 21 Suppl 2 S407-S413 [2010]
  • Development and use of FRAX in osteoporosis
    Kanis JA Osteoporos Int 21 (Suppl 2) : S407 ~ S413 [2010]
  • Daily and cyclic parathyroid hormone in women receiving alendronate
    Cosman F N Engl J Med 353 : 566 ~ 575 [2005]
  • Daily and cyclic parathyroid hormone in women receiving alendronate
    Cosman F N Engl J Med 353 566-575 [2005]
  • Cost effectiveness and cost utility of risedronate for osteoporosis treatment and fracture prevention in women: a Swiss perspective
    Wasserfallen JB J Med Econ 11 : 499 ~ 523 [2008]
  • Cost effectiveness and cost utility of risedronate for osteoporosis treatment and fracture prevention in women: a Swiss perspective
    Wasserfallen JB J Med Econ 11 499-523 [2008]
  • Back pain treatment in post-menopausal osteoporosis with vertebral fractures
    Ulivieri FM Aging Clin Exp Res 19 (3 Suppl) : 21 ~ 23 [2007]
  • Back pain treatment in post-menopausal osteoporosis with vertebral fractures
    Ulivieri FM Aging Clin Exp Res 19 3 Suppl 21-23 [2007]
  • Anabolic therapies for osteoporosis
    Uihlein AV Endocrinol Metab Clin North Am 41 : 507 ~ 525 [2012]
  • Anabolic therapies for osteoporosis
    Uihlein AV Endocrinol Metab Clin North Am 41 507-525 [2012]
  • An economic evaluation: simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures
    Nshimyumukiza L J Bone Miner Res 28 : 383 ~ 394 [2013]
  • An economic evaluation: simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures
    Nshimyumukiza L J Bone Miner Res 28 383-394 [2013]
  • Adjacent vertebral failure after vertebroplasty: a biomechanical study of low-modulus PMMA cement
    Boger A Eur Spine J 16 : 118 ~ 125 [2007]
  • Adjacent vertebral failure after vertebroplasty: a biomechanical study of low-modulus PMMA cement
    Boger A Eur Spine J 16 118-125 [2007]
  • A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures
    Buchbinder R. N Engl J Med 361 : 557 ~ 568 [2009]
  • A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures
    Buchbinder R. N Engl J Med 361 557-568 [2009]
  • A randomized trial of vertebroplasty for osteoporotic spinal fractures
    Kallmes DF N Engl J Med 361 : 569 ~ 579 [2009]
  • A randomized trial of vertebroplasty for osteoporotic spinal fractures
    Kallmes DF N Engl J Med 361 569-579 [2009]
  • A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis
    Body JJ J Clin Endocrinol Metab 87 : 4528 ~ 4535 [2002]
  • A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis
    Body JJ J Clin Endocrinol Metab 87 4528-4535 [2002]
  • A new approach to the development of assessment guidelines for osteoporosis
    Kanis JA Osteoporos Int 13 : 527 ~ 536 [2002]
  • A new approach to the development of assessment guidelines for osteoporosis
    Kanis JA Osteoporos Int 13 527-536 [2002]
  • A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture
    Hall SE Osteoporos Int 9 : 508 ~ 515 [1999]
  • A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture
    Hall SE Osteoporos Int 9 508-515 [1999]